Pharmacodynamic imaging guides dosing of a selective estrogen receptor degrader
about
Comparison of 18F-FES, 18F-FDG, and 18F-FMISO PET Imaging Probes for Early Prediction and Monitoring of Response to Endocrine Therapy in a Mouse Xenograft Model of ER-Positive Breast Cancer.Imaging of Secreted Extracellular Periostin, an Important Marker of Invasion in the Tumor Microenvironment in Esophageal Cancer.Design, construction and testing of a low-cost automated (68)Gallium-labeling synthesis unit for clinical useThe development of biomarkers to reduce attrition rate in drug discovery focused on oncology and central nervous system.Estrogen Receptor Binding (18F-FES PET) and Glycolytic Activity (18F-FDG PET) Predict Progression-Free Survival on Endocrine Therapy in Patients with ER+ Breast Cancer.18F-Fluoroestradiol PET/CT Measurement of Estrogen Receptor Suppression during a Phase I Trial of the Novel Estrogen Receptor-Targeted Therapeutic GDC-0810: Using an Imaging Biomarker to Guide Drug Dosage in Subsequent Trials.18F-16α-17β-Fluoroestradiol Binding Specificity in Estrogen Receptor-Positive Breast Cancer.Utility of 18F-fluoroestradiol (18F-FES) PET/CT imaging as a pharmacodynamic marker in patients with refractory estrogen receptor-positive solid tumors receiving Z-endoxifen therapy.Determination of binding affinity of molecular imaging agents for steroid hormone receptors in breast cancer.Somatostatin receptor type 2 as a radiotheranostic PET reporter gene for oncologic interventions.
P2860
Q36088779-114CC6FA-01D6-4F54-9039-1BF05AC77CD3Q36784269-1B7D08C7-AE63-40B0-8F85-A2BCBA17E4C0Q37136745-10EA7CB0-761D-44D4-B776-8F7CFA732606Q38907580-85EF17F4-7F3A-4A1D-A1EB-201048A33C8DQ39656587-AEDAB514-9E1D-432D-ADB3-383D048563F7Q40409656-6938E4FF-64AC-4DF2-9C40-C3BF5F06D4A5Q47732227-6375635C-B275-4BEB-90EA-D29E2E56DB88Q51311647-C610C517-C4A1-4C80-9D73-D47A27EF1906Q55069738-CF3F5810-D9B7-4B24-9066-315CDE2C642FQ55379548-64D57F66-2400-4BDC-8E99-103EEFE6F068
P2860
Pharmacodynamic imaging guides dosing of a selective estrogen receptor degrader
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Pharmacodynamic imaging guides dosing of a selective estrogen receptor degrader
@ast
Pharmacodynamic imaging guides dosing of a selective estrogen receptor degrader
@en
type
label
Pharmacodynamic imaging guides dosing of a selective estrogen receptor degrader
@ast
Pharmacodynamic imaging guides dosing of a selective estrogen receptor degrader
@en
prefLabel
Pharmacodynamic imaging guides dosing of a selective estrogen receptor degrader
@ast
Pharmacodynamic imaging guides dosing of a selective estrogen receptor degrader
@en
P2093
P2860
P1476
Pharmacodynamic imaging guides dosing of a selective estrogen receptor degrader
@en
P2093
Alicia K Leece
Neil Vasdev
Pedram Heidari
Shadi A Esfahani
Timothy M Shoup
Umar Mahmood
P2860
P304
P356
10.1158/1078-0432.CCR-14-1178
P407
P50
P577
2015-01-21T00:00:00Z